Key result
Crystallization of Seneca Valley Virus-001 yields crystals diffracting to 2.6 Å resolution.
Why the study?
Seneca Valley Virus-001 is a newly identified picornavirus with selective cytotoxicity towards neuroendocrine tumor cells, requiring structural understanding to elucidate its oncolytic properties.
Successful crystallization and preliminary X-ray diffraction of SVV-001 provides a foundation for understanding its structure and oncolytic properties.
Advances SVV-001 structural studies; leaves open clinical oncolytic translation pending higher-resolution and in vivo data.
Seneca Valley Virus-001 (SVV-001) is a newly found species in the Picornaviridae family. SVV-001 is the first naturally occurring nonpathogenic picornavirus observed to mediate selective cytotoxicity towards tumor cells with neuroendocrine cancer features. The nonsegmented (+)ssRNA genome of SVV-001 shares closest sequence similarity to the genomes of the members of the Cardiovirus genus. However, based on the distinct characteristics of the genome organization and other biochemical properties, it has been suggested that SVV-001 represents a new genus, namely 'Senecavirus', in the Picornaviridae family. In order to understand the oncolytic properties of SVV-001, the native virus was crystallized using the hanging-drop vapour-diffusion method. The crystals belonged to space group R3, with unit-cell parameters (in the hexagonal setting) a = b = 311.5, c = 1526.4 A. Although the SVV crystals diffracted to better than 2.3 A resolution, the data quality is acceptable [I/sigma(I) > 2.0] to 2.6 A resolution. The unit-cell volume and the locked rotation-function analysis suggest that six particles could be accommodated in the unit cell, with two distinct sets of one third of a particle, each containing 20 protomers, occupying the crystallographic asymmetric unit. (ClinicalTrials.gov identifier NCT00314925)
No takes yet. Share an insight, caveat, or question.
Venkataraman et al. (2008) studied Neuroendocrine cancer. Seneca Valley Virus-001 (SVV-001) was evaluated on X-ray diffraction resolution. Crystallization of the oncolytic Seneca Valley Virus-001 yielded crystals belonging to space group R3 that diffracted to 2.6 A resolution.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: